CMS-2R2-24-001: Expanding Access to Women’s Health Grant
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Center for Medicare and Medicaid Services notices from 2024.
Center for Medicare and Medicaid Services offered grants of up to $210,000 to state and local governments. It expected to make about 51 awards worth $11.1 million in total. Applications closed on August 7, 2024.
From the official notice on Grants.gov, last changed June 7, 2024. Checked November 7, 2026.
- Award ceiling$210,000
- Total funding$11.1 million
- Expected awards51
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | June 7, 2024 |
|---|---|
| Deadline | August 7, 2024 |
| Archived by Grants.gov | September 6, 2024 |
Who can apply
This opportunity was open to state and local governments.
- State governments
Is this a realistic fit?
- Past Expanding Access to Women’s Health Grant awards averaged $583,689; this notice allows up to $210,000 per award.
- Most of the program's money (100% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
Section 2794(c) of the Public Health Service Act (PHS Act) appropriates $250 million to the Secretary to award grants to States to assist them with the health insurance rate review process from fiscal years (FYs) 2010 through 2014. Section 2794(c)(2)(B) specifies that any rate review grant funds not obligated by the end of FY 2014 will remain available to the Secretary for grants to States for planning and implementing the health insurance market reforms and consumer protections under Part A of Title XXVII of the PHS Act. Applicants may use grant funds for a variety of objectives related to planning and implementation of the following pre-selected provisions of Part A of Title XXVII of the PHS Act to expand coverage of, and access to, reproductive and maternal health services I. Section 2707 – Comprehensive Health Insurance Coverage (Essential Health Benefits Package) II. Section 2713 – Coverage of Preventive Health Services
Who has won Expanding Access to Women’s Health Grant grants before
From fiscal 2021 to 2025, Expanding Access to Women’s Health Grant (93.797) awarded $8.8 million across 15 grant awards, an average of $583,689 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Pennsylvania Department of Insurance | Pennsylvania | 1 | $635,352 |
| Consumer Affairs & Business Regulation Massachusetts Office of | Massachusetts | 1 | $627,854 |
| Colorado Department of Regulatory Agencies | Colorado | 1 | $625,673 |
| New Jersey Department of Banking and Insurance | New Jersey | 1 | $624,150 |
| Insurance Commissioner, Washington State | Washington | 1 | $620,000 |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CMS-2R2-24-001 still open?
No. It closed on August 7, 2024.
Who can apply for Expanding Access to Women’s Health Grant?
Center for Medicare and Medicaid Services accepted applications from state and local governments.
What is the deadline for Expanding Access to Women’s Health Grant?
Closed August 7, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $210,000 each. About $11.1 million in total across about 51 awards.
Who has won Expanding Access to Women’s Health Grant grants before?
The largest recipients over five fiscal years were Pennsylvania Department of Insurance, Consumer Affairs & Business Regulation Massachusetts Office of, Colorado Department of Regulatory Agencies. The program made 15 awards worth $8.8 million in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)